Astellas Pharma Inc (TSE:4503)
円 2,168.5 -7.5 (-0.34%) Market Cap: 3.90 Tn Enterprise Value: 4.17 Tn PE Ratio: 13.42 PB Ratio: 2.12 GF Score: 82/100

Astellas Pharma Inc to Acquire IVERIC bio Inc M&A Presentation Transcript

May 01, 2023 / 02:00AM GMT
Release Date Price: 円2093 (+2.20%)

May 01, 2023 / 02:00AM GMT
Presentation
May 01, 2023 / 02:00AM GMT

=====================
Corporate Participants
=====================
* Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations
* Jotaro Suzuki
Astellas Pharma Inc. - VP and Primary Focus Lead of Blindness & Regeneration
* Naoki Okamura
Astellas Pharma Inc. - President, CEO,CFO & Director

=====================
Conference Call Participants
=====================
* Akinori Ueda
Goldman Sachs Group, Inc., Research Division - Equity Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kasumi Haruta
Crédit Suisse AG, Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Madoka Sato
Schroders plc - Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst
* Shinya Tsuzuki

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot